Unintended Consequences of Medical Malpractice Damages Caps

This study, by Columbia Law School Associate Professor of Law Catherine M. Sharkey, raises questions about medical liability reform initiatives premised on the assumption that caps on awards for non-economic damages in medical malpractice cases will advantage doctors, hospitals and insurers by necessarily reducing total jury compensatory awards.

An objective analysis of the efficacy of caps on non-economic damages in medical liability cases shows that awards for non-economic damages—pain and suffering, physical impairment, disfigurement, marital losses, anguish, and inconvenience—do not significantly and systematically reduce overall awards to plaintiffs. In fact, limiting non-economic damages may be contributing to a rise in economic damage—lost wages, medical expenses (past and future), rehabilitation expenses, and other financial costs.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.